Giant Cell Tumors: Clinical Trials

2 completed. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Completed 2

Follow Giant Cell Tumors: new trials by email Literature Review of Giant Cell Tumors trials Research Report on Giant Cell Tumors

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib Pexidartinib - Tenosynovial Giant Cell Tumor	Phase 4	Completed	Daiichi Sankyo	32	2020-10-20	2024-12-30
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 Denosumab - Giant Cell Tumor of Bone	Phase 4	Completed	Amgen	85	2017-11-13	2024-05-20

Narrower conditions

Giant Cell Tumor of Bone (1)  ·  Giant Cell Tumor of Tendon Sheath (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Joint Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms, Bone Tissue (1)  ·  Synovitis (1)  ·  Tendinopathy (1)

Interventions

Denosumab (1)  ·  pexidartinib (1)

Sponsors

Amgen (1)  ·  Daiichi Sankyo (1)

Countries

Australia (2)  ·  Italy (2)  ·  Spain (2)  ·  United States (2)  ·  France (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  United Kingdom (1)

NIH funding

2017 (1)